row-start col-xs-12
row-start col-md-7

英国大数据领域的先行者为亚洲带来世界领先的专业技术

国家（地区）：中国香港 / 中国大陆

一家在医疗健康领域开创了大数据分析的英国公司，即将在中国大陆地区设立第一家办事处。在此之前，该公司需要就在中国大陆引入英国技术以及其它技术订立合同。

九康全球（Nine Health Global）通过将临床与技术领域的专业知识融合，为医疗卫生领域提供人工智能（AI）和超级计算机模型的解决方案。通过将这两个领域的技术融合，在基于大量与健康相关的数据建立起实际应用这一领域，九康全球已占据了首屈一指的地位。

 

英国公司以创新改变生活的又一实例

在过去的几年中，九康全球通过与一家中国公司——杭州朗通信息技术有限公司开展合作，已经在亚洲站稳了脚跟。双方共同开发了一套自动智能辅助诊疗系统Diagbot。

在中国的2500多家诊所中，该系统可帮助临床医生对一些最常见的症状进行早期检测，比如糖尿病和呼吸疾病。Diagbot是当今市场上一款独一无二的产品，它通过运用大数据和神经网络技术，实时为临床医生推荐最佳的诊断和治疗方案。并且，在给出推荐诊断方案前，它还会自动引述最新的全国临床指南。该系统所提供的所有信息均基于病人现有的电子医疗记录。朗通信息技术公司已积累的知识图谱覆盖了100多种疾病，能够对近1000种常见疾病给出准确的诊断，并提供相关治理方案。

朗通公司总经理徐哲说道：“与九康全球公司合作已帮助我们在基础医疗领域开发出引领中国市场的产品。这在中国还是一项全新的领域。”

“想要在亚洲找到一家在医疗健康人工智能领域同时具有技术以及临床专业知识的合作伙伴是比较困难的。这也是为什么我们花费了这么多年才寻找到九康全球这样的合作伙伴。”

该业务是在2014年由英国国际贸易部（UK Department for International Trade，DIT）组织的贸易访问团到达中国时，介绍给朗通公司的。自那时起，英国国际贸易部就一直对九康全球在中国大陆和香港地区的业务提供支持，为它介绍新的业务和机遇。

最近，九康全球还与Cambridge Sound Technologies公司签订了合同，将在中国市场推广Sleep Infuser（睡眠调节仪）。这款产品能够通过复杂的声音技术，来诱导睡眠困难人群进入健康睡眠模式。

九康全球公司除在香港设立子公司外，还计划在广州生物岛（Bio-Island）设立永久性基地。此外，九康全球还与清数D-LAB签订了谅解备忘录，决定将在中国和英国的医疗健康领域开发大数据分析以及相关的服务与技术。

清数 D-LAB位于清华大学，是一家在大数据领域领先的公司。

九康全球公司的首席执行官Elaine Taylor-Whilde女士曾通过英国国民医疗服务体系（NHS）的培训成为了一名理疗师，并随后获得了信息技术、经济学和金融领域的硕士学位。她曾在英国健康与社会保健信息中心（Health and Social Care Information Centre，现为NHS Digital）开展国家临床信息研究工作，并于2011年创建了九康公司。她的团队由临床领域与技术领域的人才组成，共同朝着为医疗健康领域开发大数据分析工具这一愿景而努力。

Elaine女士认为：“我们选择进入中国大陆和香港市场因为这里蕴藏着巨大的发展机遇。除诊疗工具外，我们还一直致力于为可穿戴技术和智能消费电子产品开发软件。”

“一直以来，英国国际贸易部都在为我们在亚洲的发展提供帮助。如果没有他们，我们就不会有朗通这样的合作伙伴，也不会签署这么多合同——因为正是他们为我们提供了投标信息。英国国际贸易部的联络网是无价的，我们在发展壮大的同时也定会保持与他们的合作。”

 

UK Big data pioneers brings world-leading expertise to Asia

Country: Hong Kong / China

A UK company that is pioneering big data analytics in the healthcare sector is set to open its first offices in mainland China after securing contracts to introduce British and other technology into the country.

Nine Health Global specialises in bringing clinical and technical expertise together to produce artificial intelligence (AI) and supercomputer modelling solutions for the healthcare sector. This combination of the two skill areas makes the business a leader in the field of creating practical applications from large volumes of health-related data.

Another example of how the UK brings innovation to life

For the past few years Nine Health Global has been establishing itself in Asia by collaborating with its Chinese business partner, Hangzhou Lantone Information Technology, to develop a suite of automatic diagnostic tools called ‘Diagbot’.

Diagbot is used by clinicians for the early detection of most common conditions such as diabetes and respiratory disease in over 2,500 Chinese clinics. Diagbot is unique in the market as it uses big data and neural network technology, recommends the best diagnosis and treatment recommendations for clinicians in real time, and automatically quotes the latest national clinical guidelines before giving a diagnosis. All decisions are related to the patient's existing electronic medical records. Lantone has accumulated knowledge graph of more than one hundred diseases and is able to accurately diagnose nearly a thousand common diseases, and provide related treatment.

Victor Xu, general manager at Lantone, said: “Working with Nine Health Global has helped us create tools that are leading the way in the primary healthcare market in China, a relatively new practice area in the country.

“In Asia, finding a partner with both technical and clinical expertise in the field of healthcare AI is rare, which is why it took us years to find a partner such as Nine Health.”

The business was introduced to Lantone by the UK Department for International Trade (DIT) on a trade mission to China in 2014. Since then, the business has been fully supported by DIT in China and Hong Kong, introducing Nine Health Global to new business contacts and opportunities.

Most recently, Nine Health has signed contracts with Cambridge Sound Technologies to market the Sleep Infuser in China. The Sleep Infuser is a device that uses sophisticated sound technology to induce healthy sleep patterns in those who have trouble sleeping.

As well as establishing a subsidiary in Hong Kong, Nine Health Global also has plans to set up a permanent base on Guangzhou’s Bio-Island. The company has also signed a memorandum of understanding with Tsingdata D-Lab to develop big data analytics and related services and technology in relation to healthcare in the PRC and the UK. Tsingdata D-lab is a pioneering big data company which is based at Tsinghua University.

Nine Health CEO, Elaine Taylor-Whilde, was a trained physiotherapist in the UK’s National Health Service (NHS) before she completed a master’s degree in information technology, economics and finance. After a period as the National Clinical Lead for Research for Informatics at the Health and Social Care Information Centre (now NHS Digital). Elaine founded Nine Health in 2011 with a team of clinical and technical colleagues to take forward her aspirations to develop big data analytics tools in healthcare.

Elaine said: “We chose to expand into China and Hong Kong because of the tremendous growth opportunity it presents. Along with our diagnostic tool work, we’ve also been helping to develop software for wearable tech and smart consumer electronics.”.

“DIT has been instrumental in our success in Asia. Without them we wouldn’t have met our business partner, Lantone, or landed our most recent contracts, which it informed us were up for tender. Its contacts have been invaluable, and we will absolutely continue to work with DIT as we grow.”

col-sm-12 col-md-5 row-end top-80